Remove 2012 Remove Competition Remove Leads
article thumbnail

Global comparator data signal “alarm bells” for UK Government, says APBI

pharmaphorum

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

article thumbnail

Biosimilar medicines: the intersection of access, affordability, and innovation

European Pharmaceutical Review

Over 100 biosimilar medicines are approved for nearly 30 reference medicines, testimony to the rigour of the scientific standards leading to the European authorisation process. These reconsiderations lead the way to liberating untapped potential from biological standards of care. 6 billion in 2024 alone).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Fastest Growing Companies in Boston Hiring For Sales

CloserIQ

Founded 2012. Founded 2012. They’ve worked with leading clients such as Twitter and Mercedes Benz. Founded 2012. Founded 2012. Founded 2012. They are seeking to transform the automobile industry and are known for a fast-paced, collaborative work environment. ProfitWell. 11-50 employees. $10 See open roles.

Sales 76
article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

2 It was first approved as Fulyzaq in December 2012 and in October 2016, Napo Pharmaceuticals launched the new brand, Mytesi. 14 Marketing authorisation In the UK, medicinal products placed on the market are required to have marketing authorisations in accordance with The Human Medicines Regulations 2012 (S.I. 2012/1916).

Marketing 103
article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU. In addition, he was Head of the Legal Service at the European Medicines Agency from 2004 to 2012. effectiveness and therapeutic efficacy.

article thumbnail

Enterprising Yourself At The Top Of The Spine Distributorship Game With Daniel Tighe

Evolve Your Success

You are so spoiled if you are trying to get into this now because there’s competition in this space for you to reach that next level. Through a variety of jobs leading to this and working for a neurosurgery pharmaceutical company in an inbound call center, eventually, I got to a group called CrewAthletics.com that helped me.

Doctors 246
article thumbnail

Optimising bispecific antibody clonal cell selection with high-throughput analytics

European Pharmaceutical Review

In recent years significant improvements in automation of cell line development have reduced timelines for demonstrating productivity and clonality of lead cell lines from months to weeks. Using this data, it was possible to select a lead cell line that was scalable and produced 8 g/l across 15ml to 200l (see Figure 2 ).